+
Site Tour

Search

  • AV Valves SUMMIT 2024

    ON DEMAND AV VALVES SUMMIT 2024 2nd global edition of the AtrioVentricular Valves Summit After the success of the first edition, the AV Valves Summit was back for the second edition in Berlin…

  • AV Valves SUMMIT 2023

    ON DEMAND AV VALVES SUMMIT 2023 1st global edition of the AtrioVentricular Valves Summit The inaugural edition of AV Valves Summit established a new platform for collaboration, exploration, and…

  • Key Features

    Two Amplatzer™ ASD Closure Devices for Optimizing Patient Care Abbott offers two devices for percutaneous, transcatheter ASD closure. Amplatzer™ Septal Occluder The Amplatzer™ Septal Occluder,…

  • Patients who benefit

    The importance of treating patients with Atrial Septal Defects Patients diagnosed with an ASD, who are indicated for closure with an Amplatzer™ Septal Occluder, exhibit both6: …

  • TAVI Summit 2024

    ON DEMAND - TAVI SUMMIT 2024 2nd Abbott Annual Transcatheter Aortic Valve Implantation Summit TAVI SUMMIT 2024 With TAVI being an established therapy, it remains key to share expertise and…

  • ABBOTT AT EACTS 2024

    ABBOTT AT EACTS 2024 Connect with experts in new technologies at the techno college and visit our Abbott booth to discover the latest innovations. Join our symposium to learn about novel…

  • PDA Symposium 2024

    ON DEMAND - PDA SYMPOSIUM 2024 4th PREMICLOSE SYMPOSIUM 2024 (PDA) 4th PREMICLOSE SYMPOSIUM 2024 (PDA) PremiClose is a worldwide symposium focused on PDA closure in preterm infants. The goal…

  • Therapy

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion HOW DOES IT WORK? PROCEDURAL ANIMATION Procedure animation with…

  • LAAO Summit 2024

    ON DEMAND - LAAO SUMMIT 2024 13th International Left Atrial Appendage Occlusion Summit LAAO SUMMIT 2024 - Welcome Left Atrial Appendage Occlusion therapy has become an established and…

  • ABBOTT AT ESC 2024

    LATE-BREAKING DATA ON MITRAL AND TRICUSPID TEER At ESC 2024, 3 investigator sponsored studies (ISS) for mitral and tricuspid valve repair therapies were presented as late-breaking data: the…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline